News

The diagnostic tools are in place, but the connection between imaging machines and data management systems needs to be tighter if cardiovascular practices are going to keep up with the ever-growing patient volume, experts at Siemens Medical Solutions said from the American Heart Association's (AHA) Scientific Sessions.

Home November 12, 2006
Home
News

CoreValve’s patented ReValving System, consisting of an 18-French delivery catheter, was used to percutaneously implant ...

Home November 12, 2006
Home
News

Medtronic, Inc. has the FDA’s approval to initiate the Feasibility of the Lone Atrial Fibrillation Clinical Trial (FACT) ...

Home November 09, 2006
Home
News

Toshiba America Medical Systems, Inc. held a grand opening Wednesday of the new Toshiba Education Center, a $6 million ...

Home November 09, 2006
Home
News

The first patient of the PATRIOT (Peripheral Approach To Recanalization In Occluded Totals) U.S. pivotal study has been ...

Home November 07, 2006
Home
News

New tachycardia software for the Merlin Patient Care System by St. Jude Medical has received FDA approval. The software ...

Home November 07, 2006
Home
News

The American College of Cardiology Foundation’s National Cardiovascular Data Registry (NCDR) says it will launch a new ...

Home November 07, 2006
Home
News

An initial review of the premarket approval application for the ATS 3f(R) Aortic Bioprosthesis Heart Valve has been ...

Home November 07, 2006
Home
News

Thoratec has announced it has filed the first two modules of its Pre-Market Approval to market its HeartMate II for ...

Home November 07, 2006
Home
News

Stereotaxis has received FDA 510(k) clearance for its Niobe magnetic navigation system for use in neurovascular and ...

Home November 06, 2006
Home
News

An aspirin a day really does keep heart attack and stroke away for women, yet fewer than half of American women who could benefit from the simple measure do not take a daily pill, according to recent research.

Home November 06, 2006
Home
News

The FDA has cleared Boston Scientific’s NexStent Carotid Stent and Monorail Delivery System for use in patients with ...

Home November 06, 2006
Home
News

San Francisco-based McKesson announced it has agreed to purchase Per-Se Technologies, Alpharetta, Ga., in a deal worth $1.8 billion. The purchase is expected to close in the first quarter of 2007 if it meets regulatory approval.

Home November 06, 2006
Home
News

Results from the Phase II MEND-CABG study — which looked at demonstrated the clinical benefits of MC-1 in reducing ...

Home November 05, 2006
Home
News

A new study published in the Oct. 30 edition of “Circulation” calls the onset of peripheral arterial disease (PAD) among ...

Home November 05, 2006
Home
Subscribe Now